Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Express Scripts
Johnson and Johnson
Julphar
Argus Health
Farmers Insurance
Cantor Fitzgerald
McKesson
QuintilesIMS

Generated: February 22, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR AMBRISENTAN

« Back to Dashboard

Clinical Trials for Ambrisentan

Trial ID Title Status Sponsor Phase Summary
NCT00091598 ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH) Completed Gilead Sciences Phase 3 The primary objective is to determine the effect of ambrisentan on exercise capacity in subjects with PAH.
NCT00380068 Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary Hypertension Completed Gilead Sciences Phase 3 The primary objective of this study was to evaluate the safety and efficacy of ambrisentan in a broad population of participants with pulmonary hypertension (PH). Secondary objectives of this study were to evaluate the effects of ambrisentan on other clinical measures of pulmonary arterial hypertension (PAH), long-term treatment success, and survival.
NCT00423202 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension. Completed Gilead Sciences Phase 3 A phase 3, randomized, double-blind, placebo-controlled study to assess safety and efficacy of ambrisentan in subjects with pulmonary arterial hypertension.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Ambrisentan

Condition Name

Condition Name for Ambrisentan
Intervention Trials
Pulmonary Hypertension 14
Pulmonary Arterial Hypertension 14
Hypertension, Pulmonary 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Ambrisentan
Intervention Trials
Hypertension 38
Hypertension, Pulmonary 26
Familial Primary Pulmonary Hypertension 23
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Ambrisentan

Trials by Country

Trials by Country for Ambrisentan
Location Trials
United States 226
Germany 41
Canada 30
Australia 22
Italy 21
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Ambrisentan
Location Trials
Massachusetts 14
California 13
North Carolina 11
Texas 11
Pennsylvania 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Ambrisentan

Clinical Trial Phase

Clinical Trial Phase for Ambrisentan
Clinical Trial Phase Trials
Phase 4 9
Phase 3 14
Phase 2/Phase 3 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Ambrisentan
Clinical Trial Phase Trials
Completed 25
Recruiting 8
Active, not recruiting 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Ambrisentan

Sponsor Name

Sponsor Name for Ambrisentan
Sponsor Trials
Gilead Sciences 22
GlaxoSmithKline 11
University of Alabama at Birmingham 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Ambrisentan
Sponsor Trials
Other 70
Industry 39
NIH 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
US Department of Justice
Johnson and Johnson
Chubb
Citi
Boehringer Ingelheim
Covington
Healthtrust
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.